QL1206

denosumab · Qilu Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for QL1206, covering 2019-11-06 to 2025-07-14. Get the full timeline:

Most recent: Clinical Trial Update: A Comparative Study to Valuating the Efficacy and Safety of QL1206 and Prolia® [Phase 3]